GlassScriptPhysician profile
Ruth R Wiley
NPI 1285810291
$5,060.03
in general payments reported to CMS, 2019-2025
39 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $390 · 2021: $973 · 2022: $656 · 2023: $847 · 2024: $308 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200 · Food and Beverage: $924 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
| Food and Beverage | $924.16 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,200.00 | 2024-2025 | |
| Abbvie INC. | $1,125.16 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $311.98 | 2019-2023 | Slynd, Tyblume |
| Astellas Pharma US INC | $259.55 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $235.95 | 2021-2025 | |
| Avion Pharmaceuticals | $143.74 | 2019-2023 | Balcoltra |
| Evofem Biosciences, INC. | $135.95 | 2021 | |
| Organon LLC | $127.20 | 2021-2024 | Nexplanon, Nuvaring |
| Nevro Corp. | $118.26 | 2019-2022 | |
| Therapeuticsmd, INC. | $113.55 | 2019-2022 | |
| Covidien LP | $109.11 | 2019 | |
| Daiichi Sankyo INC. | $108.38 | 2022-2023 | Injectafer |
| Portola Pharmaceuticals, LLC | $107.60 | 2019 | |
| Millicent US INC | $97.70 | 2019-2023 | Intrarosa |
| Agile Therapeutics, INC. | $88.48 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $84.39 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $66.12 | 2021 | |
| Aspira Women'S Health INC | $64.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.95 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.63 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $46.94 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $42.34 | 2019-2020 | |
| Meditrina | $35.67 | 2022-2023 | |
| Ethicon US, LLC | $34.34 | 2021-2022 | |
| Minerva Surgical, INC | $31.20 | 2019-2024 | |
| Vertical Pharmaceuticals, LLC | $28.71 | 2019-2020 | |
| Coopersurgical, INC. | $27.32 | 2021-2022 | |
| Smith+Nephew, INC. | $23.82 | 2019 | |
| Novum Pharma, LLC | $20.93 | 2019 | |
| Baxter Healthcare | $19.56 | 2019 | |
| Duchesnay USA Incorporated | $18.32 | 2019 | |
| Merck Sharp & Dohme LLC | $18.25 | 2020 | |
| Lupin INC. | $17.91 | 2021 | |
| Pfizer INC. | $16.84 | 2019 | |
| Lilly USA, LLC | $15.59 | 2025 | Zepbound |
| Biogen, INC. | $15.43 | 2024 | Vumerity |
| Mission Pharmacal Company | $14.00 | 2020 | |
| Ibsa Pharma INC. | $12.66 | 2022 | |
| Allergan, INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.